Gujarat Themis Biosyn Ltd (GUJTHEM) โ Corporate Action | 18 September 2026 (2 announcements)
Gujarat Themis Biosyn fixed September 23, 2026 as the record date for the FY 2025-26 dividend, pending shareholder approval at the September 30 AGM.
Gujarat Themis Biosyn completed its acquisition of Japan's MicroBiopharm Japan Co., Ltd. for INR 475 crores in capital and INR 745 crores as a loan, finalizing all regulatory approvals and closing conditions. The deal adds precision fermentation capabilities, proprietary APIs, and a global footprint to GTBL's CDMO platform, enhancing diversification and margin potential.
About Gujarat Themis Biosyn Ltd (GUJTHEM)
Healthcare ยท Pharmaceuticals ยท Listed on BSE
๐ก Get AI alerts when GUJTHEM files next
Free โข Daily 5 PM digest โข Track filings, board meetings, and corporate actions
Track GUJTHEM โ Free๐ก Ask AI about this filing
๐ More GUJTHEM filings
- Announcement โ 23 September 2026Gujarat Themis Biosyn Ltd has closed its trading window effective October 1, 2026, ahead of reportin...
- ๐ก Board Meeting โ 21 September 2026Gujarat Themis Biosyn Limited issued a corrigendum to its AGM notice to amend Resolution No. 8 conce...
- ๐ด Corporate Action โ 16 September 2026Gujarat Themis Biosyn Limited allotted INR 585 crores of secured non-convertible debentures (NCDs) o...
- ๐ก Board Meeting โ 10 September 2026Gujarat Themis Biosyn approved issuing up to INR 585 Crores of private placement NCDs on 10 Septembe...
- ๐ก Board Meeting โ 8 September 2026Gujarat Themis Biosyn Limited issued an addendum to its 45th AGM notice dated September 4, 2026, con...
๐ฅ Also filed on 18 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only โ not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
๐ก Get AI alerts when GUJTHEM files new disclosures
Track GUJTHEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track GUJTHEM โ FreeFree account ยท 2 AI queries/day